Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company

Cleveland, Ohio 44114-2619

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Hormone-Sensitive Prostate Cancer, Prostatic Neoplasms

Studies at this site

• A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics — Recruiting now